Navigation Links
U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
Date:3/14/2013

EXTON, Pa., March 14, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that nephrologists believe that diabetic nephropathy is the renal condition with the highest unmet need for treatment, followed closely by acute kidney injury and polycystic kidney disease, according to TreatmentTrends: Diabetic Nephropathy (U.S.), a study of 105 U.S. physicians (52 nephrologists, 26 endocrinologists and 27 primary care physicians).

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO )

For all physician groups, angiotensin-converting-enzyme inhibitors (ACEIs) are the most prescribed class of drugs for diabetic nephropathy followed by angiotensin-receptor blockers (ARBs) and diuretics, while renin inhibitors are used the least. All physician groups use lisinopril, such as Merck's Prinvil or AstraZeneca's Zestril, more often than other ACE inhibitors. Endocrinologists prescribe ramipril, such as Pfizer's Altace or Sanofi's Triatec, significantly more often than nephrologists and primary care physicians do.

"Now that bardoxolone is no longer in development, the focus is on many new clinical compounds in development for diabetic nephropathy, including CTP-499 from Concert Pharmaceuticals or CCX140 from ChemoCentryx among others," said Rob Dubman , BioTrends' Director of Nephrology. "However, this study indicates that nephrologists are divided regarding the ideal primary end point for a product in clinical development, such as risk of doubling serum creatinine, change in creatinine clearance rate, or GFR, leading to greater complexity for the manufacturers."

TreatmentTrends®: Diabetic Nephropathy (U.S.) is a syndicated report, in which 105 U.S. physicians (52 nephrologists, 26 endocrinologists, and 27 primary care physicians) participated in an online survey. The intention of this study is to understand the diabetic nephropathy patient population, including patient load by stage and to understand what risk factors influence disease progression. In addition, this study covers the diagnosis and standard of care for patients with diabetic nephropathy and how therapy decisions differ based on disease presentation and specialty of physician treating. Finally, to understand the satisfaction with current treatment, potential for new pipeline products, and the unmet needs in the management of diabetic nephropathy.

About BioTrends Research GroupBioTrends Research Group provides syndicated and custom primary market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at www.bio-trends.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.For more information, contact:BioTrends Research Group Decision Resources GroupRob Dubman

Christopher Comfort781-993-2592

781-993-2597 rdubman@bio-trends.comccomfort@dresources.com


'/>"/>
SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. CentraState and Freehold Radiology Group train physicians from China
3. New Published Guidelines to Help Physicians Diagnose and Treat Lupus Kidney Disease
4. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
5. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
6. Physicians Practice Recognized for Print and Digital Excellence
7. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
8. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
9. Homecare Community Dismayed that Medicare Will Start Prior Authorization for Wheelchairs without a Clinical Template for Physicians to Document Need
10. Physicians Find Medical Billers and Coders Within 48 Hours of Posting Jobs with MBC
11. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Treated at Proton Therapy Centers & Forecast" report to their offering. ... The South Korean Proton ... market size in 2016. The Untapped Proton Therapy Market for ... in 2016. Proton Therapy plays an important role in ...
(Date:3/29/2017)... , March 29, 2017  Experts in the ... monitoring devices like  Soberlink Systems  as a model ... paper, published in early 2017, concluded that remote ... in managing patient recovery." The findings ... of Addiction Medicine, detail a range of variables ...
(Date:3/29/2017)... Calif. , March 29, 2017 ... for patients as the highest standard in quality ... Krypton Vision introduces its objective Wavefront-driven refraction technologies ... subjective approach. This enables an unprecedented level of ... - exceptional vision relegated to Topgun Navy fighter ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... , ... An inventor and manicurist from Greet, S.C., wants to offer people a new way ... maintain clean and healthy feet, so I know the importance of proper foot care," he ... designed the FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate ...
(Date:3/30/2017)... ... March 30, 2017 , ... This ... to President Trump expressing their support for an independent Vaccine Safety Commission. Five ... and one medical journalist, will hold a press conference at 9:00 AM ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... In the ... to 300,000 people each year develop other types of metastatic brain tumors(3). Though most ... the brain(3). As efforts focus on finding more effective treatment options, the San ...
(Date:3/29/2017)... ... ... the main cause of hay fever in the United States, with an estimated 95 percent ... to July each year; with the worst time for sufferers being June and July. ... ) provide an effective defense against grass pollen; they are proven in independent studies to ...
(Date:3/29/2017)... St. Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... Often called the "Spice of Life" or "Wonder Spice", it has been used for ... extensive use in the East," says Heshelow, author of " Turmeric: How to Use ...
Breaking Medicine News(10 mins):